Given the extreme measures the Obama Administration has gone to to keep the pending trade deal known as the TransPacific Partnership under wraps, it’s hard to be certain where things stand. Public Citizen has been relentless in publicizing leaks in combination with detailed analysis that show that this pact is not about trade, but about setting up a pro-corporate regime that would strengthen intellectual property laws (including drug patents) while allowing for “investor” panels to impose fines on governments for environmental, labor, and financial regulations that might dent their profits.